UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QEP
676
DELISTED
QEP RESOURCES, INC.
QEP
| $18.4M | 0.02% |
596,475
+10,283
| +2% | +$344K |
|
677
Carter's
CRI
$1.45B
| $18.3M | 0.02% |
235,996
-42,350
| -15% | -$3.27M |
|
|
OCR
678
DELISTED
OMNICARE INC
OCR
| $18.3M | 0.02% |
293,597
+5,355
| +2% | +$340K |
|
679
Arrow Electronics
ARW
$11.6B
| $18.2M | 0.02% |
328,774
+1,747
| +0.5% | +$105K |
|
680
Core Laboratories
CLB
$506M
| $18.1M | 0.02% |
123,828
+482
| +0.4% | +$74.4K |
|
681
Avnet
AVT
$7.72B
| $18M | 0.02% |
433,047
+1,035
| +0.2% | +$45.1K |
|
682
CEMIG Preferred Shares
CIG
$6.21B
| $18M | 0.02% |
5,657,421
+1,820,600
| +47% | +$7.47M |
|
683
Iron Mountain
IRM
$37.7B
| $17.9M | 0.02% |
548,178
-35,656
| -6% | -$1.16M |
|
|
SREV
684
DELISTED
ServiceSource International, Inc.
SREV
| $17.8M | 0.02% |
5,524,434
-2,127,763
| -28% | -$8.55M |
|
685
AMC Global Media
AMCX
$545M
| $17.8M | 0.02% |
304,731
+97,600
| +47% | +$6.02M |
|
686
American Airlines Group
AAL
$11.1B
| $17.8M | 0.02% |
501,291
+108,680
| +28% | +$4.28M |
|
687
Zions Bancorporation
ZION
$10.5B
| $17.8M | 0.02% |
611,885
+322,041
| +111% | +$9.35M |
|
688
Hilton Worldwide
HLT
$72.5B
| $17.6M | 0.02% |
237,960
+124,527
| +110% | +$9.25M |
|
689
Nasdaq
NDAQ
$53.1B
| $17.2M | 0.02% |
1,214,994
+28,203
| +2% | +$396K |
|
690
BlackBerry
BB
$5.2B
| $17M | 0.02% |
1,704,730
+334,248
| +24% | +$3.42M |
|
691
Dr. Reddy's Laboratories
RDY
$10.1B
| $17M | 0.02% |
1,617,750
+423,500
| +35% | +$3.98M |
|
|
CBL
692
DELISTED
CBL& Associates Properties, Inc.
CBL
| $17M | 0.02% |
949,479
-142,100
| -13% | -$2.69M |
|
|
SPN
693
DELISTED
Superior Energy Services, Inc.
SPN
| $16.9M | 0.02% |
51,461
+7,634
| +17% | +$2.64M |
|
694
O-I Glass
OI
$1.17B
| $16.9M | 0.02% |
647,773
-91,117
| -12% | -$2.86M |
|
695
Telefônica Brasil
VIV
$19.5B
| $16.4M | 0.02% |
835,600
+481,000
| +136% | +$9.73M |
|
|
WDR
696
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $16.4M | 0.02% |
317,619
+83,002
| +35% | +$4.62M |
|
697
ManpowerGroup
MAN
$2.54B
| $16.4M | 0.02% |
233,279
+1,359
| +0.6% | +$106K |
|
698
Novartis
NVS
$294B
| $16.3M | 0.02% |
193,434
-5,578
| -3% | -$451K |
|
699
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.13B
| – | – |
0
| – | – |
|
|
FL
700
DELISTED
Foot Locker
FL
| $15.9M | 0.02% |
285,822
+144,240
| +102% | +$7.59M |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.